Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents
NCT ID: NCT03118167
Last Updated: 2017-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
110 participants
INTERVENTIONAL
2014-05-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China Plant Sterol Trial
NCT00145717
A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in Humans
NCT02167607
Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)
NCT00721643
The Antagonistic Effect of Composite Polyphenols on Health Damage Caused by Environmental Pollutants
NCT06437119
Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
NCT00944827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tea polyphenols & Acrylamide
TP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Tea polyphenols
Tea polyphenols 0.05g, 0.1g, 0.2g (starches filled up to 0.35g), edible capsule
Acrylamide (Potato Chips)
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
AOB-w & Acrylamide
AOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
AOB-w
Water-soluble antioxidant of bamboo leaves 0.35g, edible capsule
Acrylamide (Potato Chips)
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
Placebo & Acrylamide
Placebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Placebo
Edible starches 0.35g, edible capsule
Acrylamide (Potato Chips)
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tea polyphenols
Tea polyphenols 0.05g, 0.1g, 0.2g (starches filled up to 0.35g), edible capsule
AOB-w
Water-soluble antioxidant of bamboo leaves 0.35g, edible capsule
Placebo
Edible starches 0.35g, edible capsule
Acrylamide (Potato Chips)
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Smoking or drinking
* Pregnant, trying to become pregnant or breast feeding
* Allergic frying foods
17 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu Zhang
Associate professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCT-001-AA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.